Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

NCT07227922 is registered in ClinicalTrials.gov with Sparrow Pharmaceuticals as lead sponsor.

NCT NCT07227922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07227922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Lead sponsor
Sparrow Pharmaceuticals
Phase
Phase 1
Overall status
Recruiting
Start date
November 30, 2025
Completion date
July 1, 2026
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate renal impairment